| Ciljna bolest | SARS-CoV-2 |
|---|---|
| Klinički podaci | |
| Način primene | u mišić |
Error in template * unknown parameter name (Template:Infobox_drug): "legal_BR_comment; legal_BR" (See parameter list).
This error is harmless. The message shows only in Preview, it will not show after Save.
202-CoV je kandidat za vakcinu protiv kovida 19 koju je razvio Shanghai Zerun Biotechnologi Co., Ltd., Valvak Biotech.[1][2][3]
- ^ Clinical Trials NCT04982068 Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell)
- ^ Clinical Trials NCT04990544 Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell)
- ^ „CEPI partners with Shanghai Zerun Biotech to develop COVID-19 variant vaccine”. Coalition for Epidemic Preparedness Innovations. 21. 7. 2021. Приступљено 30. 8. 2021.